---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-213348"
form_type: "8-K"
ticker: "BNTC"
cik: "0001808898"
company_name: "Benitec Biopharma Inc."
filed_at: "2024-09-05T23:59:59+00:00"
generated_at: "2026-05-31T06:17:27.426686+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Benitec stockholders approve Nasdaq-related proposal and equity plan amendment at special meeting

## Summary
- 5,947,860 shares (58.97% of outstanding) present at August 29 special meeting.
- Proposal 1 (Nasdaq) approved: 5,868,978 for, 13,614 against, 168 abstain.
- Proposal 2 (amendment to 2020 Equity Plan) approved: 5,024,173 for, 232,406 against, 626,181 abstain.
- Adjournment proposal not presented due to sufficient votes for other proposals.

## SEC filing metadata
- accession: 0001193125-24-213348
- form_type: 8-K
- ticker: BNTC
- cik: 0001808898
- company_name: Benitec Biopharma Inc.
- filed_at: 2024-09-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808898/000119312524213348/0001193125-24-213348-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808898/000119312524213348/d868099d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-213348
- JSON: https://secwatch.observer/filing/0001193125-24-213348.json
- Plain text: https://secwatch.observer/filing/0001193125-24-213348.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.